AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce its selection for the prestigious “Forbes Asia 100 to Watch 2024" list.

The “Forbes Asia 100 To Watch” is an annual feature by Forbes Asia that is now in its fourth edition. The list spotlights small companies and startups across the Asia-Pacific region that are on the rise and attracting the attention of investors.

The list can be found here and as well as in the September issue of Forbes Asia.

AIM was selected in the biotechnology and healthcare category.
For more details, please see the link below:
https://www.forbes.com/sites/forbesasiateam/2024/08/26/forbes-asia-100-to-watch-2024/

Back to list

Contact

Feel free to contact us using the form below regarding joint research,
media coverage, business partnerships, or related opportunities.